Literature DB >> 11756562

Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation.

Toshimitsu Suhara1, Hyo-Soo Kim, Lorrie A Kirshenbaum, Kenneth Walsh.   

Abstract

Fas and Fas ligand (FasL) expression has been detected in chronic vascular lesions, and Fas-mediated apoptosis of vascular smooth muscle cells (VSMC) may influence the integrity of the atherosclerotic plaque. Here we report that FasL is not expressed by normal VSMC, but its expression is upregulated by stresses that induce apoptosis, including serum deprivation, exposure to the phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor wortmannin, and ablation of Akt signaling. Conversely, constitutive activation of Akt signaling diminished FasL expression in VSMC cultures exposed to low-mitogen media or wortmannin. Under conditions of suppressed PI 3-kinase/Akt signaling, VSMC apoptosis was partially inhibited by treatment with neutralizing antibody against FasL. Suppression of Akt signaling increased the activity of c-Jun N-terminal kinase, and transduction of dominant-negative c-Jun inhibited FasL induction under these conditions. Diminished Akt signaling promoted the cleavage of caspase 3, and both caspase 3 cleavage and FasL induction were inhibited by transduction of dominant-negative caspase 9 or the caspase 8 inhibitor CrmA. Similarly, induction of FasL by the Akt-regulated forkhead transcription factor FKHRL1 was dependent upon caspase and c-Jun activation. Taken together, these results indicate that the sequential activation of caspase 3 and c-Jun participates in the induction of FasL under conditions of suppressed Akt signaling or FKHRL1 activation and that FasL participates in a positive-feedback loop to promote cell death under conditions of cellular stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756562      PMCID: PMC139747          DOI: 10.1128/MCB.22.2.680-691.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

1.  Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis.

Authors:  S Strand; W J Hofmann; A Grambihler; H Hug; M Volkmann; G Otto; H Wesch; S M Mariani; V Hack; W Stremmel; P H Krammer; P R Galle
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

2.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease.

Authors:  M J Pollman; J L Hall; M J Mann; L Zhang; G H Gibbons
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

4.  Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1.

Authors:  J C Deak; J V Cross; M Lewis; Y Qian; L A Parrott; C W Distelhorst; D J Templeton
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation.

Authors:  M Sata; K Walsh
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

6.  Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response.

Authors:  M Sata; H Perlman; D A Muruve; M Silver; M Ikebe; T A Libermann; P Oettgen; K Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

7.  Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells.

Authors:  H Hug; S Strand; A Grambihler; J Galle; V Hack; W Stremmel; P H Krammer; P R Galle
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

8.  Downregulation of Fas ligand by shedding.

Authors:  M Tanaka; T Itai; M Adachi; S Nagata
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

9.  MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis.

Authors:  C Widmann; P Gerwins; N L Johnson; M B Jarpe; G L Johnson
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

10.  Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis.

Authors:  A O Hueber; M Zörnig; D Lyon; T Suda; S Nagata; G I Evan
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

View more
  51 in total

1.  Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase.

Authors:  Jee-Yin Ahn; Xia Liu; Zhixue Liu; Lorena Pereira; Dongmei Cheng; Junmin Peng; Paul A Wade; Anne W Hamburger; Keqiang Ye
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

2.  Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma.

Authors:  Martina Rudelius; Stefania Pittaluga; Satoshi Nishizuka; Trinh H-T Pham; Falko Fend; Elaine S Jaffe; Leticia Quintanilla-Martinez; Mark Raffeld
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

Review 3.  Forkhead transcription factors and cardiovascular biology.

Authors:  Kyriakos N Papanicolaou; Yasuhiro Izumiya; Kenneth Walsh
Journal:  Circ Res       Date:  2008-01-04       Impact factor: 17.367

4.  Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Authors:  Deepa Sampath; Jorge Cortes; Zeev Estrov; Min Du; Zheng Shi; Michael Andreeff; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

5.  Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver disease.

Authors:  Scott J Cotler; Nissim Hay; Hui Xie; Mei Ling Chen; Pei Zhang Xu; Thomas J Layden; Grace Guzman
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

6.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

7.  Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.

Authors:  Alicja Dabrowska; Nayoung Kim; Anna Aldovini
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.

Authors:  Hector Guillen-Ahlers; Mark A Suckow; Francis J Castellino; Victoria A Ploplis
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

9.  Akt2 inhibition enables the forkhead transcription factor FoxO3a to have a repressive role in estrogen receptor alpha transcriptional activity in breast cancer cells.

Authors:  Catia Morelli; Marilena Lanzino; Cecilia Garofalo; Pamela Maris; Elvira Brunelli; Ivan Casaburi; Stefania Catalano; Rosalinda Bruno; Diego Sisci; Sebastiano Andò
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

Review 10.  Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.

Authors:  Jacqueline Whyte; Orla Bergin; Alessandro Bianchi; Sara McNally; Finian Martin
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.